Asahi Kasei Corp. (TYO:3407) is pursuing a growth strategy for its Health Care sector, with aims here being to achieve…...
Please subscribe to read the full story.
Pharma
Sumitomo Dainippon Pharma to Expand Regenerative and Cellular Medicine CDMO Operations
Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) and Sumitomo Chemical Co. Ltd. (TYO:4005) plan to expand their CDMO facilities for regenerative…...
Please subscribe to read the full story.
Japan’s Leading Drug Manufacturers Grow Sales Revenue on Back of Mainstay Products
Drug manufacturers across Japan have now released their business results for fiscal 2021. Looking at companies using the April–March fiscal…...
Please subscribe to read the full story.
